Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

Quia Pharma AB (publ) (QUIA.ST)

Compare
0.0094
+0.0036
+(62.07%)
At close: April 4 at 5:29:38 PM GMT+2
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cost of Revenue
-460
-460
-4,374
-3,334
-311
Gross Profit
460
460
4,374
3,334
311
Operating Expense
29,125
29,125
19,886
19,128
17,880
Operating Income
-28,665
-28,665
-15,512
-15,794
-17,569
Net Non Operating Interest Income Expense
-264
-264
-1,011
-4,295
-2,431
Pretax Income
-28,929
-28,929
-16,523
-20,089
-20,000
Net Income Common Stockholders
-28,929
-28,929
-16,523
-20,089
-20,000
Diluted NI Available to Com Stockholders
-28,929
-28,929
-16,523
-20,089
-20,000
Basic EPS
-0.02
--
-0.02
-0.08
-11.86
Diluted EPS
-0.02
--
-0.02
-0.08
-11.86
Basic Average Shares
1,264,634.6690
--
656,826.2900
236,217.0870
1,690.7820
Diluted Average Shares
1,264,634.6690
--
656,826.2900
236,217.0870
1,690.7820
Total Operating Income as Reported
-28,665
-28,665
-15,512
-15,794
-17,569
Total Expenses
28,665
28,665
15,512
15,794
17,569
Net Income from Continuing & Discontinued Operation
-28,929
-28,929
-16,523
-20,089
-20,000
Normalized Income
-28,929
-28,929
-16,523
-20,089
-20,000
Interest Income
1
1
2
--
--
Interest Expense
265
265
1,013
4,295
2,431
Net Interest Income
-264
-264
-1,011
-4,295
-2,431
EBIT
-28,664
-28,664
-15,510
-15,794
-17,569
EBITDA
-9,712
-9,712
-11,651
-12,426
-15,368
Reconciled Cost of Revenue
-460
-460
-4,374
-3,334
-311
Reconciled Depreciation
18,952
18,952
3,859
3,368
2,201
Net Income from Continuing Operation Net Minority Interest
-28,929
-28,929
-16,523
-20,089
-20,000
Normalized EBITDA
-9,712
-9,712
-11,651
-12,426
-15,368
12/31/2021 - 6/21/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers